^
BIOMARKER:
IDH1 mutation
i
Other names: HEL-216, HEL-S-26, Epididymis Luminal Protein 216, Isocitrate Dehydrogenase 1 (NADP+), Epididymis Secretory Protein Li 26, IDH1, Isocitrate Dehydrogenase (NADP(+)) 1, Isocitrate Dehydrogenase 1 (NADP+), Soluble
Entrez ID:
Related biomarkers:
IDH1 mutation
Cholangiocarcinoma
ivosidenib
Sensitive
:
A2
Servier Press Release - 1wk
IDH1 mutation
AML
ivosidenib
Sensitive
:
A1
IDH1 mutation
AML
venetoclax
Sensitive
:
A2
IDH1 mutation
Glioma
temozolomide gel
Sensitive
:
B
IDH1 mutation
AML
gilteritinib
Resistant
:
B
IDH1 mutation
Glioma
PCV
Sensitive
:
B
IDH1 mutation
Glioma
ivosidenib
Sensitive
:
C1
IDH1 mutation
Astrocytoma
temozolomide
Sensitive
:
C2
IDH1 mutation
Glioma
temozolomide
Sensitive
:
C2
IDH1 mutation
Glioma
TG02
Sensitive
:
C3
IDH1 mutation
AML
cytarabine/daunorubicin liposomal formulation
Sensitive
:
C3
IDH1 mutation
AML
venetoclax + ABBV-621
Sensitive
:
C3
IDH1 mutation
AML
FT-2102
Sensitive
:
C3
IDH1 mutation
GBM
temozolomide
Sensitive
:
C3
IDH1 mutation
GBM
pembrolizumab
Resistant
:
C3
IDH1 mutation
AML
CFI-400945
Sensitive
:
C3
IDH1 mutation
AML
venetoclax + midostaurin
Resistant
:
C3
IDH1 mutation
AML
venetoclax + gilteritinib
Resistant
:
C3
IDH1 mutation
AML
venetoclax + sorafenib
Resistant
:
C3
IDH1 mutation
CMML
venetoclax
Sensitive
:
C3
IDH1 mutation
Glioma
BAY1436032
Sensitive
:
C3
IDH1 mutation
Anaplastic Astrocytoma
PCV
Sensitive
:
C3
IDH1 mutation
GBM
NEO100
Sensitive
:
C3
IDH1 mutation
Sarcoma
olaparib
Sensitive
:
C3
IDH1 mutation
AML
ABBV-744
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our